CNBX Pharmaceuticals (CNBX Pharmaceuticals) Enterprise Value : $1.55 Mil (As of May. 15, 2024)

CNBX Pharmaceuticals Enterprise Value Chart

CNBX Pharmaceuticals Annual Data
	Trend	Aug14	Aug15	Aug16	Aug17	Aug18	Aug19	Aug20	Aug21	Aug22	Aug23
Enterprise Value		Get a 7-Day Free Trial					31.56	25.02	24.76	5.92	1.60

CNBX Pharmaceuticals Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Enterprise Value	Get a 7-Day Free Trial															1.71	1.62	1.60	1.57	1.63

Competitive Comparison of CNBX Pharmaceuticals's Enterprise Value

For the Biotechnology subindustry, CNBX Pharmaceuticals's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CNBX Pharmaceuticals's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CNBX Pharmaceuticals's Enterprise Value distribution charts can be found below:

* The bar in red indicates where CNBX Pharmaceuticals's Enterprise Value falls into.

CNBX Pharmaceuticals Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

CNBX Pharmaceuticals's Enterprise Value for the fiscal year that ended in Aug. 2023 is calculated as

CNBX Pharmaceuticals's Enterprise Value for the quarter that ended in Feb. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CNBX Pharmaceuticals  (OTCPK:CNBX) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

CNBX Pharmaceuticals's EV-to-EBIT for today is

CNBX Pharmaceuticals's current Enterprise Value is $1.55 Mil.
CNBX Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.49 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

CNBX Pharmaceuticals's EV-to-EBITDA for today is:

CNBX Pharmaceuticals's current Enterprise Value is $1.55 Mil.
CNBX Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.34 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

CNBX Pharmaceuticals's EV-to-Revenue for today is:

CNBX Pharmaceuticals's current Enterprise Value is $1.55 Mil.
CNBX Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CNBX Pharmaceuticals Enterprise Value Related Terms

Thank you for viewing the detailed overview of CNBX Pharmaceuticals's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

CNBX Pharmaceuticals (CNBX Pharmaceuticals) Business Description